The effect of LRRK2 loss-of-function variants in humans

Nicola Whiffin(Broad Institute), Molly Schleicher(Broad Institute), Miguel Covarrubias(Broad Institute), Kristen M. Connolly(Broad Institute), David Roazen(Broad Institute), Irina M. Armean(Broad Institute), Steven Ferriera(Broad Institute), Benjamin M. Neale(Broad Institute), Beryl B. Cummings(Rapt Therapeutics (United States)), Ryan L. Collins(Broad Institute), Aaron Kleinman(23andMe (United States)), Babak Alipanahi(Google (United States)), Eric Banks(Broad Institute), Peter Morrison(23andMe (United States)), Valentín Ruano-Rubio(Broad Institute), Eric Vallabh Minikel(Broad Institute), Marco A. S. Baptista(Merck & Co., Inc., Rahway, NJ, USA (United States)), Anna Guan(23andMe (United States)), Ruchi Munshi, Jeff Gentry(Broad Institute), Kaitlin E. Samocha(Broad Institute), Laurent C. Francioli(Broad Institute), Andrea Saltzman(Broad Institute), Diane Kaplan(Broad Institute), Julia K. Goodrich(Broad Institute), Kristian Cibulskis(Broad Institute), Jamie L. Marshall(Solidus Biosciences (United States)), Timothy Poterba(Broad Institute), Stacey Gabriel(Broad Institute), Thibault Jeandet(Broad Institute), Joanne B. Cole(Broad Institute), Yossi Farjoun(Broad Institute), Nikelle Petrillo(Broad Institute), Sam Novod(Broad Institute), Louis Bergelson(Broad Institute), Qingbo S. Wang(The University of Tokyo), Laura D. Gauthier(Broad Institute), Christopher Llanwarne(Broad Institute), Stacey Donnelly(Broad Institute), Nicholas M. Quaife(Guy's and St Thomas' NHS Foundation Trust), Juliana C.N. Chan(Chinese University of Hong Kong), Namrata Gupta(Broad Institute), Konrad J. Karczewski(Broad Institute), Mark J. Daly(Broad Institute), Anne O’Donnell‐Luria(Broad Institute), Kristen M. Laricchia(Broad Institute)
Nature Medicine
May 27, 2020
Cited by 113


Related Papers